These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Targeted nanomaterials for radiotherapy. Escorcia FE; McDevitt MR; Villa CH; Scheinberg DA Nanomedicine (Lond); 2007 Dec; 2(6):805-15. PubMed ID: 18095847 [TBL] [Abstract][Full Text] [Related]
26. Stimuli-Responsive Nanomaterials for Application in Antitumor Therapy and Drug Delivery. Pham SH; Choi Y; Choi J Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32635539 [TBL] [Abstract][Full Text] [Related]
27. Updates on smart polymeric carrier systems for protein delivery. El-Sherbiny I; Khalil I; Ali I; Yacoub M Drug Dev Ind Pharm; 2017 Oct; 43(10):1567-1583. PubMed ID: 28581834 [TBL] [Abstract][Full Text] [Related]
28. Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances. Jash A; Ubeyitogullari A; Rizvi SSH J Mater Chem B; 2021 Jun; 9(24):4773-4792. PubMed ID: 34027542 [TBL] [Abstract][Full Text] [Related]
29. Self-assembled peptide nanomaterials for biomedical applications: promises and pitfalls. Sun L; Zheng C; Webster TJ Int J Nanomedicine; 2017; 12():73-86. PubMed ID: 28053525 [TBL] [Abstract][Full Text] [Related]
30. Stimuli-Responsive Self-Assembled DNA Nanomaterials for Biomedical Applications. Dai Z; Leung HM; Lo PK Small; 2017 Feb; 13(7):. PubMed ID: 28005298 [TBL] [Abstract][Full Text] [Related]
31. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment. Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269 [TBL] [Abstract][Full Text] [Related]
32. Construction of Smart Stimuli-Responsive DNA Nanostructures for Biomedical Applications. Wang H; Luo D; Wang H; Wang F; Liu X Chemistry; 2021 Feb; 27(12):3929-3943. PubMed ID: 32830363 [TBL] [Abstract][Full Text] [Related]
33. Reversible stimuli-responsive nanomaterials with on-off switching ability for biomedical applications. Alejo T; Uson L; Arruebo M J Control Release; 2019 Nov; 314():162-176. PubMed ID: 31644937 [TBL] [Abstract][Full Text] [Related]
34. Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives. Tesauro D; Accardo A; Diaferia C; Milano V; Guillon J; Ronga L; Rossi F Molecules; 2019 Jan; 24(2):. PubMed ID: 30669445 [TBL] [Abstract][Full Text] [Related]
35. Novel delivery technologies for protein and peptide therapeutics. Kumar TR; Soppimath K; Nachaegari SK Curr Pharm Biotechnol; 2006 Aug; 7(4):261-76. PubMed ID: 16918403 [TBL] [Abstract][Full Text] [Related]
36. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook. Song Y; Li Y; Xu Q; Liu Z Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526 [TBL] [Abstract][Full Text] [Related]
37. Recent Advances in Anti-cancer Protein/Peptide Delivery. Liu X; Wu F; Ji Y; Yin L Bioconjug Chem; 2019 Feb; 30(2):305-324. PubMed ID: 30428665 [TBL] [Abstract][Full Text] [Related]
38. [Targeted nanomedicine in diagnostics and therapy of neurological diseases]. Bertalan F; László B; Attila V Ideggyogy Sz; 2013 May; 66(5-6):155-63. PubMed ID: 23909015 [TBL] [Abstract][Full Text] [Related]
39. Airway delivery of peptides and proteins using nanoparticles. Dombu CY; Betbeder D Biomaterials; 2013 Jan; 34(2):516-25. PubMed ID: 23046753 [TBL] [Abstract][Full Text] [Related]